NDRG1 has been shown to suppress metastasis in pancreatic, ovarian and colorectal cancers, whereas in lung, cervical and hepatocellular cancers, NDRG1 has been associated with tumour progression [9]. Here, NDRG1 is linked to hepatocellular carcinoma.